Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 3Withdrawn 1Unknown 1Completed 1

Sponsor Class

OTHER 4OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 11Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Vomiting 1Ulcer 1Stomatitis 1Skin Cancer Face 1Recurrence 1Pathologic Complete Response 1Parasomnias 1Pain, Intractable 1Ovarian Neoplasms 1Opportunistic Infections 1Neoplasm Metastasis 1Nausea 1Melanoma 1Medulloblastoma 1Lung Neoplasms 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Kidney Neoplasms 1Inflammation 1Hepatitis C, Chronic 1Hepatitis C 1Hematologic Neoplasms 1Glioblastoma 1Fatigue 1Esophageal Neoplasms 1Epstein-Barr Virus Infections 1

Interventions

pertuzumab 1Trastuzumab 1Epirubicin 1Docetaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × OTHER_GOV × Pathologic Complete Response × Clear all
NCT05474690 2024-02-26

A Study Comparing the Efficacy of TCbHP and ECHP-THP in the Neoadjuvant Treatment of HER2-positive Breast Cancer

Henan Cancer Hospital

Phase 3 Withdrawn
Breast

Pathologic Complete Response, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡